Clinical Trial Update: Naproxen for the Prevention of HO After Complex Elbow Trauma [Phase 4]

View source ↗

Summary

A Phase 4 trial of naproxen for preventing heterotopic ossification after complex elbow trauma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterotopic Ossification

Drugs mentioned

• Naproxen (Naproxen)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Heterotopic Ossification | Phase 4 | Status: WITHDRAWN